Disruption of cell adhesion by an antibody targeting the cell-adhesive intermediate (X-dimer) of human P-cadherin

Shota Kudo, Jose M.M. Caaveiro, Satoru Nagatoishi, Takamitsu Miyafusa, Tadashi Matsuura, Yukio Sudou, Kouhei Tsumoto

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Human P-cadherin is a cell adhesion protein of the family of classical cadherins, the overexpression of which is correlated with poor prognosis in various types of cancer. Antibodies inhibiting cell-cell adhesion mediated by P-cadherin show clear therapeutic effect, although the mechanistic basis explaining their effectiveness is still unclear. Based on structural, physicochemical, and functional analyses, we have elucidated the molecular mechanism of disruption of cell adhesion by antibodies targeting human P-cadherin. Herein we have studied three different antibodies, TSP5, TSP7, and TSP11, each recognizing a different epitope on the surface of the cell-adhesive domain (EC1). Although all these three antibodies recognized human P-cadherin with high affinity, only TSP7 disrupted cell adhesion. Notably, we demonstrated that TSP7 abolishes cell adhesion by disabling the so-called X-dimer (a kinetic adhesive intermediate), in addition to disrupting the strand-swap dimer (the final thermodynamic state). The inhibition of the X-dimer was crucial for the overall inhibitory effect, raising the therapeutic value of a kinetic intermediary not only for preventing, but also for reversing, cell adhesion mediated by a member of the classical cadherin family. These findings should help to design more innovative and effective therapeutic solutions targeting human P-cadherin.

Original languageEnglish
Article number39518
JournalScientific reports
Volume7
DOIs
Publication statusPublished - Jan 3 2017
Externally publishedYes

Fingerprint

Cadherins
Cell Adhesion
Adhesives
Antibodies
Therapeutic Uses
iocarmate meglumine
Thermodynamics
Epitopes
Neoplasms
Proteins

All Science Journal Classification (ASJC) codes

  • General

Cite this

Disruption of cell adhesion by an antibody targeting the cell-adhesive intermediate (X-dimer) of human P-cadherin. / Kudo, Shota; Caaveiro, Jose M.M.; Nagatoishi, Satoru; Miyafusa, Takamitsu; Matsuura, Tadashi; Sudou, Yukio; Tsumoto, Kouhei.

In: Scientific reports, Vol. 7, 39518, 03.01.2017.

Research output: Contribution to journalArticle

Kudo, Shota ; Caaveiro, Jose M.M. ; Nagatoishi, Satoru ; Miyafusa, Takamitsu ; Matsuura, Tadashi ; Sudou, Yukio ; Tsumoto, Kouhei. / Disruption of cell adhesion by an antibody targeting the cell-adhesive intermediate (X-dimer) of human P-cadherin. In: Scientific reports. 2017 ; Vol. 7.
@article{3d3f8b24605947dc8ddee917bd83515d,
title = "Disruption of cell adhesion by an antibody targeting the cell-adhesive intermediate (X-dimer) of human P-cadherin",
abstract = "Human P-cadherin is a cell adhesion protein of the family of classical cadherins, the overexpression of which is correlated with poor prognosis in various types of cancer. Antibodies inhibiting cell-cell adhesion mediated by P-cadherin show clear therapeutic effect, although the mechanistic basis explaining their effectiveness is still unclear. Based on structural, physicochemical, and functional analyses, we have elucidated the molecular mechanism of disruption of cell adhesion by antibodies targeting human P-cadherin. Herein we have studied three different antibodies, TSP5, TSP7, and TSP11, each recognizing a different epitope on the surface of the cell-adhesive domain (EC1). Although all these three antibodies recognized human P-cadherin with high affinity, only TSP7 disrupted cell adhesion. Notably, we demonstrated that TSP7 abolishes cell adhesion by disabling the so-called X-dimer (a kinetic adhesive intermediate), in addition to disrupting the strand-swap dimer (the final thermodynamic state). The inhibition of the X-dimer was crucial for the overall inhibitory effect, raising the therapeutic value of a kinetic intermediary not only for preventing, but also for reversing, cell adhesion mediated by a member of the classical cadherin family. These findings should help to design more innovative and effective therapeutic solutions targeting human P-cadherin.",
author = "Shota Kudo and Caaveiro, {Jose M.M.} and Satoru Nagatoishi and Takamitsu Miyafusa and Tadashi Matsuura and Yukio Sudou and Kouhei Tsumoto",
year = "2017",
month = "1",
day = "3",
doi = "10.1038/srep39518",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Disruption of cell adhesion by an antibody targeting the cell-adhesive intermediate (X-dimer) of human P-cadherin

AU - Kudo, Shota

AU - Caaveiro, Jose M.M.

AU - Nagatoishi, Satoru

AU - Miyafusa, Takamitsu

AU - Matsuura, Tadashi

AU - Sudou, Yukio

AU - Tsumoto, Kouhei

PY - 2017/1/3

Y1 - 2017/1/3

N2 - Human P-cadherin is a cell adhesion protein of the family of classical cadherins, the overexpression of which is correlated with poor prognosis in various types of cancer. Antibodies inhibiting cell-cell adhesion mediated by P-cadherin show clear therapeutic effect, although the mechanistic basis explaining their effectiveness is still unclear. Based on structural, physicochemical, and functional analyses, we have elucidated the molecular mechanism of disruption of cell adhesion by antibodies targeting human P-cadherin. Herein we have studied three different antibodies, TSP5, TSP7, and TSP11, each recognizing a different epitope on the surface of the cell-adhesive domain (EC1). Although all these three antibodies recognized human P-cadherin with high affinity, only TSP7 disrupted cell adhesion. Notably, we demonstrated that TSP7 abolishes cell adhesion by disabling the so-called X-dimer (a kinetic adhesive intermediate), in addition to disrupting the strand-swap dimer (the final thermodynamic state). The inhibition of the X-dimer was crucial for the overall inhibitory effect, raising the therapeutic value of a kinetic intermediary not only for preventing, but also for reversing, cell adhesion mediated by a member of the classical cadherin family. These findings should help to design more innovative and effective therapeutic solutions targeting human P-cadherin.

AB - Human P-cadherin is a cell adhesion protein of the family of classical cadherins, the overexpression of which is correlated with poor prognosis in various types of cancer. Antibodies inhibiting cell-cell adhesion mediated by P-cadherin show clear therapeutic effect, although the mechanistic basis explaining their effectiveness is still unclear. Based on structural, physicochemical, and functional analyses, we have elucidated the molecular mechanism of disruption of cell adhesion by antibodies targeting human P-cadherin. Herein we have studied three different antibodies, TSP5, TSP7, and TSP11, each recognizing a different epitope on the surface of the cell-adhesive domain (EC1). Although all these three antibodies recognized human P-cadherin with high affinity, only TSP7 disrupted cell adhesion. Notably, we demonstrated that TSP7 abolishes cell adhesion by disabling the so-called X-dimer (a kinetic adhesive intermediate), in addition to disrupting the strand-swap dimer (the final thermodynamic state). The inhibition of the X-dimer was crucial for the overall inhibitory effect, raising the therapeutic value of a kinetic intermediary not only for preventing, but also for reversing, cell adhesion mediated by a member of the classical cadherin family. These findings should help to design more innovative and effective therapeutic solutions targeting human P-cadherin.

UR - http://www.scopus.com/inward/record.url?scp=85008391857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008391857&partnerID=8YFLogxK

U2 - 10.1038/srep39518

DO - 10.1038/srep39518

M3 - Article

C2 - 28045038

AN - SCOPUS:85008391857

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 39518

ER -